Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA ‘Weirdness?’ Separate meetings for BioMarin and Sarepta DMD drugs
FDA ‘Weirdness?’ Separate meetings for BioMarin and Sarepta DMD drugs
FDA ‘Weirdness?’ Separate meetings for BioMarin and Sarepta DMD drugs
Submitted by
admin
on October 15, 2015 - 3:59pm
Source:
Pharmalot
News Tags:
FDA
Biomarin
Sarepta Therapeutics
Duchenne Muscular Dystrophy
eteplirsen
drisapersen
Headline:
FDA ‘Weirdness?’ Separate meetings for BioMarin and Sarepta DMD drugs
Do Not Allow Advertisers to Use My Personal information
